戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                       The molecular basis of erythrocyte sedimentation is unknown.
2 ture >38.3 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
3 ture >38.8 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
4 ions (P = 0.01), myositis (P = 0.02), and an erythrocyte sedimentation rate >40 mm/hour (P < 0.001) w
5  (49.7 mg/L; reference range, 0.0-8.0 mg/L), erythrocyte sedimentation rate (>140 mm/h with Westergre
6 L; reference range, 0.0-0.5 mg/dL), elevated erythrocyte sedimentation rate (60 mm/h; reference range
7 L; reference range, 0.0-0.5 mg/dL), elevated erythrocyte sedimentation rate (60 mm/h; reference range
8              Inflammatory markers, including erythrocyte sedimentation rate (7 mm per hour; normal ra
9 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
10 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
11 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
12 isease Activity Score in 28 joints using the erythrocyte sedimentation rate (DAS28-ESR) was >/=3.2.
13 hange in Disease Activity Score in 28 joints-Erythrocyte Sedimentation Rate (DAS28-ESR).
14 ips, or proximal aspects of the thighs), and erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
15 ck, shoulders, or hip girdle regions; and an erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
16 e age <65 years (OR = 10.647, P = 0.023) and erythrocyte sedimentation rate (ESR) >30 (OR = 6.414, P
17 (adjusted OR, 2.71 [95% CI, 1.26-5.86]), and erythrocyte sedimentation rate (ESR) >40 mm/h (adjusted
18 variate analysis, age younger than 60 years, erythrocyte sedimentation rate (ESR) 20 mm/h or less, an
19                                              Erythrocyte sedimentation rate (ESR) and C-reactive prot
20                                              Erythrocyte sedimentation rate (ESR) and C-reactive prot
21  There is a positive correlation between the erythrocyte sedimentation rate (ESR) and large bowel upt
22 ents were assessed for correlations with the erythrocyte sedimentation rate (ESR) and platelet count.
23 riate analysis for EFS are stage of disease, erythrocyte sedimentation rate (ESR) at diagnosis, liver
24 of the respondents reported using either the erythrocyte sedimentation rate (ESR) or C-reactive prote
25 ), RA disease activity score 28 (DAS28), and erythrocyte sedimentation rate (ESR) were measured at ba
26 th, the Health Assessment Questionnaire, and erythrocyte sedimentation rate (ESR) were used to develo
27                     "Controllers" had normal erythrocyte sedimentation rate (ESR) without M. tubercul
28 nderness, 3) physician global assessment, 4) erythrocyte sedimentation rate (ESR), 5) functional disa
29                                          The erythrocyte sedimentation rate (ESR), a commonly perform
30              Age greater than 50 years, high erythrocyte sedimentation rate (ESR), and bilateral AION
31 s were calculated to estimate effect of age, erythrocyte sedimentation rate (ESR), and C-reactive pro
32  effect of acupuncture on morning stiffness, erythrocyte sedimentation rate (ESR), and C-reactive pro
33 and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and platelets for
34 a, hematuria, low hemoglobin level, elevated erythrocyte sedimentation rate (ESR), and presence of an
35       Participants with IBD-AD showed higher erythrocyte sedimentation rate (ESR), C-reactive protein
36 ere obtained periodically for measurement of erythrocyte sedimentation rate (ESR), C-reactive protein
37 and analyzed for complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein
38 nd rheumatoid factor-negative polyarthritis, erythrocyte sedimentation rate (ESR), C-reactive protein
39  fasting insulin, glucose, and lipid levels, erythrocyte sedimentation rate (ESR), C-reactive protein
40 at every visit included determination of the erythrocyte sedimentation rate (ESR), grip strength, pai
41 ic markers such as C-reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR), haemoglobin-A1C (H
42 lesterol, triglycerides, C-reactive protein, erythrocyte sedimentation rate (ESR), hemoglobin, total
43                                 The elevated erythrocyte sedimentation rate (ESR), IgG, neopterin, an
44                          C-reactive protein, erythrocyte sedimentation rate (ESR), rheumatoid factor,
45 rythrocyte aggregation were also determined: erythrocyte sedimentation rate (ESR), zeta sedimentation
46  I tests, stimulated salivary flow, IgG, and erythrocyte sedimentation rate (ESR).
47 ctive measures of dry eyes, and IgG level or erythrocyte sedimentation rate (ESR).
48 r and swollen joints, grip strength, and the erythrocyte sedimentation rate (ESR).
49 nt counts for pain and tenderness and higher erythrocyte sedimentation rate (ESR).
50 levels, C-reactive protein (CRP) levels, and erythrocyte sedimentation rate (ESR).
51 host-related [age; hematological parameters; erythrocyte sedimentation rate (ESR); C-reactive protein
52 tor (RF) positivity (93% versus 84%), higher erythrocyte sedimentation rate (ESR; 45 versus 36 mm/hr)
53 CI) 0.03-0.35, P < 0.0005]), as was a higher erythrocyte sedimentation rate (HR 0.80 [95% CI 0.67-0.9
54  smoking (OR 1.02, P = 0.04) and an elevated erythrocyte sedimentation rate (OR 1.02, P = 0.05) were
55 phocytosis (OR, 1.84; P = 0.0002), increased erythrocyte sedimentation rate (OR, 6.5; P = 0.0005), de
56 .039), low serum C4 (P = 0.046), an elevated erythrocyte sedimentation rate (P = 0.006), and abnormal
57 -glycoprotein concentration (p = 0.012), and erythrocyte sedimentation rate (p = 0.01); concentration
58 creases in albumin (P<.001) and decreases in erythrocyte sedimentation rate (P<.05), interleukin-6 (P
59 ated patients had greater mean reductions in erythrocyte sedimentation rate (p=0.009) and a two-fold
60 italization (P=0.05) and, at week 1, a lower erythrocyte sedimentation rate (P=0.02) and a tendency t
61 nt 29.4, mean swollen joint count 17.4, mean erythrocyte sedimentation rate 25.1 mm/hour) despite tre
62 ints, Larsen radiographic score 20 versus 3, erythrocyte sedimentation rate 33 mm/hour versus 20, and
63 6 months (mean tender joint count 28.2, mean erythrocyte sedimentation rate 46.5 mm/hour) were random
64 ctivity (disease activity score in 28 joints-erythrocyte sedimentation rate [DAS28-ESR] >/= 3.2 [rang
65 [LDA] according to Disease Activity Score 28-erythrocyte sedimentation rate [DAS28-ESR] </=3.2 or DAS
66  correlated with untreated disease activity (erythrocyte sedimentation rate [ESR]) (r = 0.5, P = 0.00
67 ammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (t
68 hysician's and patient's global assessments, erythrocyte sedimentation rate [ESR], and morning stiffn
69 atory markers (white blood cell [WBC] count, erythrocyte sedimentation rate [ESR], C-reactive protein
70 enderness, swelling, and deformity, nodules, erythrocyte sedimentation rate [ESR], C-reactive protein
71 onnaire), and serum markers of inflammation (erythrocyte sedimentation rate [ESR], high-sensitivity C
72 rity (rheumatoid factor [RF] seropositivity, erythrocyte sedimentation rate [ESR], joint swelling, ra
73 respectively, of 0.54-0.78 and 0.46-0.95 for erythrocyte sedimentation rate and 0.73 and 0.78 for C-r
74                                          The erythrocyte sedimentation rate and C-reactive protein le
75                                          The erythrocyte sedimentation rate and C-reactive protein le
76                                   Westergren erythrocyte sedimentation rate and C-reactive protein va
77                                          The erythrocyte sedimentation rate and C-reactive protein va
78                                              Erythrocyte sedimentation rate and C-reactive protein we
79 mality of common inflammatory markers (i.e., erythrocyte sedimentation rate and C-reactive protein) w
80 ing, and normalization of C-reactive protein/erythrocyte sedimentation rate and calprotectin.
81 ned the relation between leukocyte count and erythrocyte sedimentation rate and diabetes incidence us
82 related with biomarkers of disease activity (erythrocyte sedimentation rate and double-stranded DNA c
83 serum albumin; MR was associated with higher erythrocyte sedimentation rate and lower albumin at all
84                                     Elevated erythrocyte sedimentation rate and serum creatinine leve
85 cular dysfunction was associated with higher erythrocyte sedimentation rate and, at diagnosis only, l
86                     Marked elevations of the erythrocyte sedimentation rate and/or C-reactive protein
87                       C-reactive protein and erythrocyte sedimentation rate are commonly used biochem
88 demonstrated that a model which included the erythrocyte sedimentation rate at baseline (P = 0.005) a
89 ients who entered the trial with an elevated erythrocyte sedimentation rate but normal CRP level.
90                       C-reactive protein and erythrocyte sedimentation rate declined by 50% and 28%,
91                               The Westergren erythrocyte sedimentation rate declined more in the PsA
92                               The Westergren erythrocyte sedimentation rate declined more with SSZ tr
93 f 5.29 mg to 0.34 mg per deciliter), and the erythrocyte sedimentation rate decreased at month 3 (all
94                                          The erythrocyte sedimentation rate decreased in patients 2,
95  osteomyelitis may have an increase in their erythrocyte sedimentation rate during the first 2 weeks
96 ps with regard to abnormal elevations of the erythrocyte sedimentation rate following initial remissi
97 of amyloid A and C-reactive protein, and the erythrocyte sedimentation rate from baseline to month 3
98      Eighty-nine percent of patients have an erythrocyte sedimentation rate greater than 50 mm/h.
99 naire Disability Scale, global severity, and erythrocyte sedimentation rate had a 3-6 times increased
100                                              Erythrocyte sedimentation rate had the lowest correlatio
101             Tests for C-reactive protein and erythrocyte sedimentation rate have been used to assess
102 ch as HLA-B27 status, C-reactive protein and erythrocyte sedimentation rate have, at best, moderate d
103          The SE was associated with a higher erythrocyte sedimentation rate in women and more frequen
104 evated peripheral white blood cell count and erythrocyte sedimentation rate may herald an infection o
105 of tocilizumab, the C-reactive protein level/erythrocyte sedimentation rate normalized, while placebo
106 usted hazard ratios for participants with an erythrocyte sedimentation rate of > or = 26 mm/hour comp
107 6 mm/hour compared with participants with an erythrocyte sedimentation rate of < or = 5 mm/hour were
108 f 8.5 IU/mL (normal range, 0-13.9 IU/mL), an erythrocyte sedimentation rate of 2 mm/hr (normal range,
109 % eosinophils [normal range, 1%-4%]), and an erythrocyte sedimentation rate of 31 mm per hour (normal
110 ormal value, <10 mg/L [95.2 nmol/L]), and an erythrocyte sedimentation rate of 35 mm per hour (normal
111 l of 47 g/L (normal range, 26-32 g/L) and an erythrocyte sedimentation rate of 36 mm/h (normal range,
112 el of less than 5 mg/L (47.6 nmol/L), and an erythrocyte sedimentation rate of 41 mm/h (0-15 mm/h).
113 % eosinophils [normal range, 1%-4%]), and an erythrocyte sedimentation rate of 5 mm per hour (normal
114               Laboratory work-up revealed an erythrocyte sedimentation rate of 58 mm/h (reference ran
115 th the inflammatory variant have an elevated erythrocyte sedimentation rate or abnormalities of other
116 , even without immediate availability of the erythrocyte sedimentation rate or the C-reactive protein
117 o had higher baseline C-reactive protein and erythrocyte sedimentation rate than the persistent CP gr
118                                          Her erythrocyte sedimentation rate was elevated at 56 mm/h,
119 he most frequent presenting symptom, and the erythrocyte sedimentation rate was elevated in 98% of ca
120                              Clinically, the erythrocyte sedimentation rate was inversely correlated
121  lower physical QOL during followup, whereas erythrocyte sedimentation rate was most strongly associa
122 7.023), and 2.9-fold higher when an elevated erythrocyte sedimentation rate was present (p = 0.077, O
123 and C-reactive protein (CRP), as well as the erythrocyte sedimentation rate were measured serially.
124 ESR (disease activity score in 28 joints for erythrocyte sedimentation rate) and complement system ge
125 natriuretic peptide, C-reactive protein, and erythrocyte sedimentation rate), an electrocardiogram, t
126 dules, rheumatoid factor seropositivity, and erythrocyte sedimentation rate).
127 nia, thrombocytosis, C-reactive protein, and erythrocyte sedimentation rate); and (3) vasculopathy si
128 ed by disease duration, 5% by the Westergren erythrocyte sedimentation rate, 14% by articular signs a
129 27% traditional bulk (> 10 cm), 52% elevated erythrocyte sedimentation rate, 21% extranodal involveme
130  acute-phase reactants (C-reactive protein), erythrocyte sedimentation rate, and bone metabolism mark
131 ng hormone level, autoimmune antibody level, erythrocyte sedimentation rate, and C-reactive protein l
132 d culture, electrolyte panel, liver enzymes, erythrocyte sedimentation rate, and C-reactive protein l
133 me) and disease activity (total joint count, erythrocyte sedimentation rate, and C-reactive protein)
134 uality of life, enthesitis, chest expansion, erythrocyte sedimentation rate, and C-reactive protein,
135                                    Male sex, erythrocyte sedimentation rate, and Carstairs Deprivatio
136 , exhibited higher C-reactive protein (CRP), erythrocyte sedimentation rate, and comorbidities such a
137 plained, statistically, by pain, depression, erythrocyte sedimentation rate, and disease duration.
138                          C-reactive protein, erythrocyte sedimentation rate, and fecal calprotectin w
139 ood glucose, urinary albumin creatine ratio, erythrocyte sedimentation rate, and high-sensitivity C-r
140 mation markers C-reactive protein (CRP), the erythrocyte sedimentation rate, and interleukin-6 (IL-6)
141  minutes, elevated C-reactive protein and/or erythrocyte sedimentation rate, and new hip pain.
142 ated with a reduction in C-reactive protein, erythrocyte sedimentation rate, and pericardial LGE in t
143 ectively), and lower white blood cell count, erythrocyte sedimentation rate, and platelet count (all
144 l sites, lactate dehydrogenase (LDH) levels, erythrocyte sedimentation rate, and platelet count did n
145 ndspread, lung involvement, muscle weakness, erythrocyte sedimentation rate, and platelet count.
146 gher anti-double-stranded DNA (dsDNA) titer, erythrocyte sedimentation rate, and SLE Disease Activity
147 seline and week 4 in the tender joint count, erythrocyte sedimentation rate, and urinary excretion of
148 k factors (ie, age, clinical stage, elevated erythrocyte sedimentation rate, B symptoms, large medias
149 ), joint swelling, joint pain or tenderness, erythrocyte sedimentation rate, C-reactive protein level
150                        Complete blood count, erythrocyte sedimentation rate, C-reactive protein level
151 markers of inflammation (such as leukocytes, erythrocyte sedimentation rate, C-reactive protein, and
152            We evaluated the following tests: erythrocyte sedimentation rate, C-reactive protein, feca
153 African American patients with PN had higher erythrocyte sedimentation rate, C-reactive protein, ferr
154 e with blood tests (Xpert MTB host-response, erythrocyte sedimentation rate, C-reactive protein, Quan
155 f the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-reactive protein, tube
156                  Inflammatory markers (ESR - erythrocyte sedimentation rate, CRP - C-reactive protein
157 (anemia, thrombocytopenia leukocytosis, high erythrocyte sedimentation rate, elevated levels of C-rea
158 tional diagnostic tests include blood tests (erythrocyte sedimentation rate, ESR; C-reactive protein,
159 ious infection, corticosteroid use, elevated erythrocyte sedimentation rate, extraarticular manifesta
160 on, and basic blood tests, which include the erythrocyte sedimentation rate, hemoglobin, white count,
161 greater physical function limitation, higher erythrocyte sedimentation rate, higher joint count sever
162 ngoing inflammation as indicated by elevated erythrocyte sedimentation rate, hypocomplementemia, and/
163 cts were noted in individual ACR components, erythrocyte sedimentation rate, onset of ACR20 response,
164 ficant improvement in 3 of 5 core variables (erythrocyte sedimentation rate, physician's global asses
165 4) levels were significantly reduced, as was erythrocyte sedimentation rate, possibly as a result of
166 orrelated with the C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor level,
167  disease duration, C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, nodul
168 interval 1.18-12.59], P=0.026) alongside the erythrocyte sedimentation rate, triglyceride level, pred
169                       The second best marker-erythrocyte sedimentation rate-improved the area under t
170 se reactants, such as C-reactive protein and erythrocyte sedimentation rate.
171  joints with limited range of motion; and 6) erythrocyte sedimentation rate.
172 odified Health Assessment Questionnaire, and erythrocyte sedimentation rate.
173 arrhea, fever, weight loss, and an increased erythrocyte sedimentation rate.
174  normal C-reactive protein level, and normal erythrocyte sedimentation rate.
175 perlipidemia is indicated by their increased erythrocyte sedimentation rate.
176 e protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.
177 th the presence of nephritis and an elevated erythrocyte sedimentation rate.
178 elated, in part, to smoking and an increased erythrocyte sedimentation rate.
179 eumatologist ranked ACR 20, radiography, and erythrocyte sedimentation rate/c-reactive protein as the
180 m/electrocardiogram), and laboratory workup (erythrocyte sedimentation rate/C-reactive protein).
181 ne kinase, thyroid-stimulating hormones, and erythrocyte sedimentation rate; all analyses were perfor
182                                        Serum erythrocyte sedimentation rate; C-reactive protein, inte
183 ures [3 patient and 3 assessor measures plus erythrocyte sedimentation rate]); 3) patient-only (media
184                                 Although the erythrocyte-sedimentation rate, C-reactive protein, and
185 tionship with disease activity score 28 with erythrocytes sedimentation rate (DAS28[ESR]) and Sharp s
186 tive protein concentrations (>/=6.9 mg/L) or erythrocyte sedimentation rates (>/=18 mm/h).
187                                              Erythrocyte sedimentation rates (ESRs), C3 levels, C4 le
188 nts who experienced complications had higher erythrocyte sedimentation rates (P<0.001) and C-reactive
189 articipants, the use of drugs was noted, and erythrocyte sedimentation rates and serum levels of high
190 eline levels of C-reactive protein and lower erythrocyte sedimentation rates compared with patients d
191 joint counts, C-reactive protein levels, and erythrocyte sedimentation rates had fallen significantly
192  those for the C-reactive protein levels and erythrocyte sedimentation rates in the same patients.
193  erythrocytes may contribute to the elevated erythrocyte sedimentation rates observed in inflammatory
194                       C-reactive protein and erythrocyte sedimentation rates were elevated in most ca
195                C-reactive protein levels and erythrocyte sedimentation rates were significantly highe
196 d significantly increased neutrophil counts, erythrocyte sedimentation rates, and C-reactive protein,
197 mplete blood cell counts, metabolic factors, erythrocyte sedimentation rates, and levels of C-reactiv

 
Page Top